Key Takeaways Novo Nordisk shares gained Monday as the company said it would present new data on the ability of semaglutide, ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...

A long-term Novo Nordisk A/S skeptic recommended buying shares of the Danish weight-loss drug maker nine years after starting ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Swiss pharmaceutical company Roche struck a multibillion-dollar collaboration and licensing deal with Zealand Pharma to co-develop a weight-loss treatment. Roche's stock rallied in Europe, while ...

Woman says she got less expensive drug for weight loss after being denied by insurance Both Eli Lilly and Novo Nordisk now ...